Mounjaro, Lilly and European Union
Eli Lilly (NYSE: LLY) may seem like an expensive stock to invest in right now. Its $720 billion market capitalization also ...
14hon MSN
We recently compiled a list of the 16 Best Income Stocks To Buy According to Analysts. In this article, we are going to take ...
Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.
Eli Lilly And Co (LLY) stock saw a modest uptick, ending the day at $789.12 which represents a slight increase of $6.77 or 0.87% from the prior close of $782.35. The stock opened at $777.13 and ...
Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo ...
Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.
Eli Lilly will start studying its obesity products as treatments for alcohol and drug abuse, making it the first major ...
Buy Rating for Eli Lilly & Co: Strategic Developments and Promising Oncology Pipeline Drive Optimism
Jefferies analyst Akash Tewari maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of $994.00. Pick the best stocks and maximize your portfolio: Discover ...
Eli Lilly is partnering with the Flatiron-based telehealth company Ro to sell a cheaper version of its popular weight-loss ...
Direct-to-consumer health and wellness company Ro will now offer access to lower-priced, single-dose vials of weight loss ...
It is made possible through a first-of-a-kind integration with Eli Lilly’s direct-to-consumer website, and aims to streamline ...
Amid new worries that legal copycats of the weight-loss drugs from Eli Lilly and Novo Nordisk could erode the market for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback